Emily Nelson is the new chief flight director for NASA. Photo via NASA.org

The Mission Control Center at NASA’s Johnson Space Center in Houston has a new chief flight director.

In her new role, Emily Nelson leads the group that directs human spaceflight missions. She succeeds Amarillo native Holly Ridings, who held the job from 2018 to 2022. Ridings now is a leader of NASA’s Gateway Program, which is working to establish the first space station that orbits the moon.

“Emily’s tenure leading our flight control teams has proven that she is remarkably knowledgeable on the realities of human spaceflight and eminently composed when facing daunting challenges,” Norm Knight, NASA’s director of flight operations, says in a news release. “She is unequivocally the right person to lead our flight director office as we endeavor to push the boundaries of human spaceflight exploration.”

Nelson manages 31 flight directors and directors-in-training who oversee a human spaceflight missions involving the International Space Station and Artemis missions to the moon.

Nelson, born in Okinawa, Japan, and raised in Austin, earned a bachelor’s degree in mechanical engineering from the University of Texas at Austin in 1998. She joined NASA in 1998 as a flight controller in the space station’s thermal operations group.

She became a flight director in 2007. Since then, she has served as lead flight director for several missions, including the station’s fourth utilization and logistics flight with the space shuttle Atlantis in 2010 and a series of spacewalks to repair the Alpha Magnetic Spectrometer. She had been NASA’s deputy chief flight director before being named acting chief flight director following Ridings’ departure.

In 2018, Nelson completed a record-breaking 735th shift as a flight director at Mission Control.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”